Padmashri Dr. Kamal Haasan Unveils the Revolutionary Geniee Mobile Application

Neuberg Diagnostics, a global leader in cutting-edge healthcare diagnostics, has officially launched its ground-breaking personalized genomics platform, “Geniee – Decode your DNA”. This launch signifies a monumental shift in the future of personalized healthcare, positioning Neuberg Diagnostics at the forefront of genetic testing and tailored medicine.

The event was graced by Padma shri Dr. Kamal Haasan, who unveiled the Geniee brand, marking the beginning of an innovative journey that will enable individuals to unlock their genetic blueprint. Neuberg’s Geniee is designed to deliver highly personalized health insights, empowering users with the knowledge needed to make informed decisions about their health and wellness based on their unique genetic makeup.

Geniee by Neuberg is more than just a risk prediction tool; it’s a personalized wellness revolution. This mobile platform provides insights into how your genes influence your body’s response to medications, dietary preferences, exercise routines, and nutritional needs. It enables users to take control of their health by offering comprehensive genetic insights into critical aspects of well-being. With Geniee, individuals can optimize their diets, identify nutrient deficiencies, enhance fitness plans, and take proactive steps to ensure a healthier future.

The launch of the Complete Wellness Genetics Test along with the Geniee app is at the heart of this initiative. This advanced genetic analysis dives deep into a person’s DNA, offering clear guidance on how they can adjust their lifestyle to live longer, healthier lives. Whether it’s determining if you are prone to be obese, have nutritional deficiencies like vitamin A deficiency, and recommend the best foods for optimal nutrition or identifying potential health risks early on, Geniee empowers users to personalize their health strategy and transform their well-being. Considering the ever growing scientific advancement in genomics, Geniee customers will benefit from regular updates on the app that they will get based on their unique genetic make-up and recent updates.

Dr. GSK Velu, Chairman & Managing Director of Neuberg Diagnostics, addressed the audience at the launch, stating: “At Neuberg, we believe that personalized medicine is the future of healthcare. The launch of Geniee is a testament to our commitment to driving this future forward. Geniee is not just about testing—it’s about giving individuals the power to take control of their health by offering them invaluable insights. We are thrilled to have Dr. Kamal Haasan with us today to unveil this milestone, as we aim to push the boundaries of medical science and deliver better healthcare outcomes for all.”

Geniee by Neuberg offers personalized genomic programs that help in the early detection of health risks, providing customized health plans based on each individual’s genetic profile. This initiative embodies Neuberg’s dedication to making healthcare more proactive, accessible, and tailored to each person’s unique genetic code. Geniee leverages the power of pharmacogenomics, a discipline that examines how our unique genetic makeup influences our response to medications. Geinee comprehensive genetic testing helps individuals and healthcare providers understand how their body processes and responds to drugs.

“A truly revolutionary step in the realm of personalized medicine. Genomics has the power to transform healthcare by offering tailored health insights based on an individual’s unique genetic makeup. Geniee empowers people to take control of their health, make informed decisions, and adopt preventive measures that could shape their future well-being. This is a major leap forward in our pursuit of personalized wellness, and I believe it will pave the way for a healthier and more informed society.” Said Padmashri Dr Kamal Haasan.

Dr. Sandip Shah, Joint Managing Director of Neuberg Diagnostics, enthused about the revolutionary impact of Geniee, saying, “Pharmacogenomics is at the heart of Geniee, and it is changing the landscape of medicine. It represents a paradigm shift in healthcare, where the one-size-fits-all approach is replaced with tailored treatments based on a person’s genetic makeup. This game-changing service aligns with our commitment to excellence in diagnostics and patient care.”

By understanding the genetic factors affecting drug metabolism and response, healthcare providers can modify the dosage or shift to alternative drugs which may suit the patient better. Adverse Drug Reactions (ADR) accounts for 6.7% of all hospitalizations, 4^th most common cause of inpatient death. This increases medical cost and affects patient wellbeing. This precision medicine approach reduces the need for ineffective treatments and decreases the risk of patients experiencing side effects or adverse reactions by 30%.

“A Recent study on pharmacogenomics landscape in the Indian population revealed each Indian individual carries on an average eight variants directly impacting medication dose and type of medicine.” added Dr Sandip Shah.

Dr. Sandip Shah, Joint Managing Director of Neuberg Diagnostics, Padma shri Dr. Kamal Haasan, Dr. GSK Velu, Chairman & Managing Director of Neuberg Diagnostics and Mr A Ganesan, Vice Chairman Neuberg Diagnostics

Mr A Ganesan, Vice Chairman Neuberg Diagnostics, Dr. Sandip Shah, Joint Managing Director of Neuberg Diagnostics, Padma shri Dr. Kamal Haasan and Dr. GSK Velu, Chairman & Managing Director of Neuberg Diagnostics